Regulation of pro-inflammatory responses by lipoxygenases via intracellular reactive oxygen species in vitro and in vivo.
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3858/emm.2008.40.4.461
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		So Yong KIM
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Tae Bum KIM
			        		
			        		;
		        		
		        		
		        		
			        		Keun Ai MOON
			        		
			        		;
		        		
		        		
		        		
			        		Tae Jin KIM
			        		
			        		;
		        		
		        		
		        		
			        		Dongwoo SHIN
			        		
			        		;
		        		
		        		
		        		
			        		You Sook CHO
			        		
			        		;
		        		
		        		
		        		
			        		Hee Bom MOON
			        		
			        		;
		        		
		        		
		        		
			        		Ki Young LEE
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Korea. thylee@med.skku.ac.kr
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		anti-inflammatory agents;
			        		
			        		
			        		
				        		asthma;
			        		
			        		
			        		
				        		lipoxygenase;
			        		
			        		
			        		
				        		macrophages;
			        		
			        		
			        		
				        		models, animal;
			        		
			        		
			        		
				        		NF-kappa B;
			        		
			        		
			        		
				        		reactive oxygen species
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Animals;
				        		
			        		
				        		
					        		Antioxidants/metabolism;
				        		
			        		
				        		
					        		Asthma/complications/metabolism/pathology/physiopathology;
				        		
			        		
				        		
					        		Bronchial Hyperreactivity/drug therapy/pathology;
				        		
			        		
				        		
					        		Bronchial Provocation Tests;
				        		
			        		
				        		
					        		Bronchoalveolar Lavage Fluid/cytology;
				        		
			        		
				        		
					        		Cells, Cultured;
				        		
			        		
				        		
					        		Drug Evaluation, Preclinical;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Inflammation/*etiology/metabolism;
				        		
			        		
				        		
					        		Jurkat Cells;
				        		
			        		
				        		
					        		Lipoxygenase/*physiology;
				        		
			        		
				        		
					        		Lipoxygenase Inhibitors/pharmacology/therapeutic use;
				        		
			        		
				        		
					        		Lymphocytes/drug effects/metabolism;
				        		
			        		
				        		
					        		Male;
				        		
			        		
				        		
					        		Mice;
				        		
			        		
				        		
					        		Mice, Inbred BALB C;
				        		
			        		
				        		
					        		Nordihydroguaiaretic Acid/pharmacology/therapeutic use;
				        		
			        		
				        		
					        		Reactive Oxygen Species/*adverse effects/*metabolism
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:Experimental & Molecular Medicine
	            		
	            		 2008;40(4):461-476
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:English
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Reactive oxygen species (ROS) performs a pivotal function as a signaling mediator in receptor-mediated signaling. However, the sources of ROS in this signaling have yet to be determined, but may include lipoxygenases (LOXs) and NADPH oxidase. The stimulation of lymphoid cells with TNF-alpha, IL-1beta, and LPS resulted in significant ROS production and NF-kappaB activation. Intriguingly, these responses were markedly abolished via treatment with the LOXs inhibitor nordihydroguaiaretic acid (NDGA). We further examined in vivo anti-inflammatory effects of NDGA in allergic airway inflammation. Both intraperitoneal and intravenous NDGA administration attenuated ovalbumin (OVA)-induced influx into the lungs of total leukocytes, as well as IL-4, IL-5, IL-13, and TNF-alpha levels. NDGA also significantly reduced serum levels of OVA-specific IgE and suppressed OVA-induced airway hyperresponsiveness to inhaled methacholine. The results of our histological studies and flow cytometric analyses showed that NDGA inhibits OVA-induced lung inflammation and the infiltration of CD11b+ macrophages into the lung. Collectively, our findings indicate that LOXs performs an essential function in pro-inflammatory signaling via the regulation of ROS regulation, and also that the inhibition of LOXs activity may have therapeutic potential with regard to the treatment of allergic airway inflammation.